HealthEquity, Inc. (NASDAQ:HQY) Shares Bought by Strs Ohio

Strs Ohio raised its holdings in HealthEquity, Inc. (NASDAQ:HQY) by 49.1% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 16,100 shares of the company’s stock after acquiring an additional 5,300 shares during the quarter. Strs Ohio’s holdings in HealthEquity were worth $1,067,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds also recently bought and sold shares of the business. Fifth Third Bancorp lifted its stake in HealthEquity by 36.5% during the third quarter. Fifth Third Bancorp now owns 602 shares of the company’s stock valued at $44,000 after buying an additional 161 shares in the last quarter. Sheets Smith Wealth Management lifted its stake in HealthEquity by 2.5% during the third quarter. Sheets Smith Wealth Management now owns 7,921 shares of the company’s stock valued at $579,000 after buying an additional 191 shares in the last quarter. HighTower Advisors LLC lifted its stake in HealthEquity by 0.4% during the third quarter. HighTower Advisors LLC now owns 86,940 shares of the company’s stock valued at $6,366,000 after buying an additional 340 shares in the last quarter. Mariner LLC lifted its stake in HealthEquity by 2.4% during the third quarter. Mariner LLC now owns 14,983 shares of the company’s stock valued at $1,095,000 after buying an additional 345 shares in the last quarter. Finally, McGlone Suttner Wealth Management Inc. purchased a new stake in HealthEquity during the fourth quarter valued at about $29,000. 99.55% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at HealthEquity

In related news, EVP Delano Ladd sold 2,499 shares of the business’s stock in a transaction on Friday, February 9th. The shares were sold at an average price of $80.00, for a total transaction of $199,920.00. Following the transaction, the executive vice president now owns 49,996 shares of the company’s stock, valued at $3,999,680. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In related news, EVP Delano Ladd sold 2,499 shares of the business’s stock in a transaction on Friday, February 9th. The shares were sold at an average price of $80.00, for a total transaction of $199,920.00. Following the transaction, the executive vice president now owns 49,996 shares of the company’s stock, valued at $3,999,680. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Evelyn S. Dilsaver sold 32,500 shares of the business’s stock in a transaction on Tuesday, March 26th. The stock was sold at an average price of $79.29, for a total transaction of $2,576,925.00. Following the transaction, the director now directly owns 32,123 shares in the company, valued at approximately $2,547,032.67. The disclosure for this sale can be found here. Insiders have sold a total of 71,322 shares of company stock worth $5,682,895 over the last 90 days. Insiders own 2.70% of the company’s stock.

HealthEquity Trading Down 1.6 %

Shares of HQY stock opened at $79.87 on Wednesday. HealthEquity, Inc. has a 12 month low of $48.86 and a 12 month high of $84.49. The company has a quick ratio of 4.76, a current ratio of 4.76 and a debt-to-equity ratio of 0.43. The business’s 50 day moving average is $81.09 and its two-hundred day moving average is $74.34. The company has a market cap of $6.85 billion, a PE ratio of 124.80, a price-to-earnings-growth ratio of 1.32 and a beta of 0.53.

HealthEquity (NASDAQ:HQY) last announced its quarterly earnings results on Tuesday, March 19th. The company reported $0.50 EPS for the quarter, beating the consensus estimate of $0.42 by $0.08. HealthEquity had a return on equity of 6.91% and a net margin of 5.57%. The company had revenue of $262.39 million for the quarter, compared to the consensus estimate of $258.56 million. Equities analysts predict that HealthEquity, Inc. will post 2.12 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of analysts have commented on the stock. JMP Securities began coverage on shares of HealthEquity in a research note on Thursday, April 4th. They set a “mkt outperform” rating and a $101.00 price objective for the company. Bank of America increased their price target on shares of HealthEquity from $93.00 to $97.00 and gave the stock a “buy” rating in a research report on Wednesday, March 20th. BTIG Research increased their price target on shares of HealthEquity from $100.00 to $110.00 and gave the stock a “buy” rating in a research report on Wednesday, March 20th. Barrington Research reissued an “outperform” rating and issued a $100.00 price target on shares of HealthEquity in a research report on Friday, March 22nd. Finally, JPMorgan Chase & Co. increased their price target on shares of HealthEquity from $86.00 to $108.00 and gave the stock an “overweight” rating in a research report on Tuesday, April 2nd. One investment analyst has rated the stock with a hold rating and eleven have given a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $96.17.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.